Breast cancer: hormones and other risk factors.
暂无分享,去创建一个
[1] M. Coleman,et al. Trends in cancer incidence and mortality. , 1993, IARC scientific publications.
[2] E. Weiderpass,et al. Risks of breast and endometrial cancer after estrogen and estrogen–progestin replacement , 1999, Cancer Causes & Control.
[3] T. Key,et al. Endogenous estrogen and postmenopausal breast cancer: a quantitative review , 1997, Cancer Causes & Control.
[4] M. Pike,et al. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies , 1990, Cancer Causes & Control.
[5] W. Willett,et al. Nutrition and breast cancer , 2004, Cancer Causes & Control.
[6] B. Ponder,et al. A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk 1 , 2000 .
[7] C. Weinberg,et al. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk , 1999, Public Health Nutrition.
[8] Taylor Murray,et al. Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.
[9] M. Pike,et al. Soy intake and risk of breast cancer in Asians and Asian Americans. , 1998, The American journal of clinical nutrition.
[10] N. Boyd,et al. Mammographic densities and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] D. Osei-Hyiaman,et al. Timing of menopause, reproductive years, and bone mineral density: a cross-sectional study of postmenopausal Japanese women. , 1998, American journal of epidemiology.
[12] J. Kelsey,et al. Electric blanket use and breast cancer risk among younger women. , 1998, American journal of epidemiology.
[13] J. Manson,et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. , 1998, Journal of the National Cancer Institute.
[14] B. Weber,et al. BRCA1 and BRCA2: from molecular genetics to clinical medicine. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] F. Speizer,et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. , 1998, JAMA.
[16] E. John,et al. Recreational and occupational physical activities and risk of breast cancer. , 1998, Journal of the National Cancer Institute.
[17] F. Laden,et al. Environmental risk factors and female breast cancer. , 1998, Annual review of public health.
[18] JoAnn E. Manson,et al. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.
[19] Julian Peto,et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.
[20] S. Cummings,et al. Sex steroid hormones, bone mineral density, and risk of breast cancer. , 1997, Environmental health perspectives.
[21] R. Tarone,et al. Birth cohort and calendar period trends in breast cancer mortality in the United States and Canada. , 1997, Journal of the National Cancer Institute.
[22] M. King,et al. Genetic epidemiology of breast and ovarian cancers. , 1997, Epidemiologic reviews.
[23] B A Miller,et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. , 1996, Journal of the National Cancer Institute.
[24] C. Longcope,et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[25] Julian Peto,et al. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.
[26] W. Willett,et al. Jewish religion and risk of breast cancer , 1996, The Lancet.
[27] B. Hulka,et al. Breast cancer: cause and prevention , 1995, The Lancet.
[28] G A Colditz,et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.
[29] N. Robert,et al. Estrogen Replacement Therapy in Breast Cancer Survivors-Reply , 1995 .
[30] P. Strax,et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. , 1995, Journal of the National Cancer Institute.
[31] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[32] N. Robert,et al. Estrogen Replacement Therapy in Breast Cancer Survivors: A Time for Change , 1994 .
[33] N. Robert,et al. Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group. , 1994, JAMA.
[34] M. Longnecker,et al. Alcohol and breast cancer. Where are we now where do we go from here? , 1994, Cancer.
[35] H. Adami,et al. Transient increase in the risk of breast cancer after giving birth. , 1994, The New England journal of medicine.
[36] W. Willett,et al. Lactation and a reduced risk of premenopausal breast cancer. , 1994, The New England journal of medicine.
[37] D. W. Thompson. Genetic epidemiology of breast cancer , 1994, Cancer.
[38] J. Ferlay,et al. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden , 1993, International journal of cancer.
[39] P. Disaia,et al. Hormone replacement therapy In breast cancer , 1993, The Lancet.
[40] Marydale Debor,et al. Quality determinants of mammography , 1993 .
[41] J. Manson,et al. Antioxidant micronutrients and breast cancer. , 1993, Journal of the American College of Nutrition.
[42] J L Kelsey,et al. Breast cancer: magnitude of the problem and descriptive epidemiology. , 1993, Epidemiologic reviews.
[43] G. Colditz,et al. A prospective study of benign breast disease and the risk of breast cancer , 1992, JAMA.
[44] S. Shapiro,et al. Breast cancer and cigarette smoking: a hypothesis. , 1991, American journal of epidemiology.
[45] B. Henderson,et al. Decreased Mortality in Users of Estrogen Replacement Therapy , 1991, Archives of internal medicine.
[46] M. Pike,et al. Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. , 1990, British Journal of Cancer.
[47] C. Mendelson,et al. The role of adipose tissue in estrogen biosynthesis in the human , 1990 .
[48] R. Frisch. Adipose tissue and reproduction , 1990 .
[49] H A Risch,et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. , 1989, The New England journal of medicine.
[50] R. Shore,et al. The risk of breast cancer after irradiation of the thymus in infancy. , 1989, The New England journal of medicine.
[51] H. Adami,et al. PROGNOSIS AFTER BREAST CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY , 1989 .
[52] L. Kuller,et al. The epidemiology of serum sex hormones in postmenopausal women. , 1989, American journal of epidemiology.
[53] K. McPherson,et al. Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy , 1988, British journal of obstetrics and gynaecology.
[54] S Graham,et al. Alcohol and breast cancer. , 1987, The New England journal of medicine.
[55] W D Dupont,et al. Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.
[56] B. Macmahon,et al. Menopause and breast cancer risk. , 1972, Journal of the National Cancer Institute.
[57] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.